Nepafenac

CHEMBL1021 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
254.3 g/mol
LogP
1.9
Phase
4

This non-steroidal anti-inflammatory eye drop is used to treat pain and inflammation after cataract surgery and to reduce the risk of swelling in the retina. It penetrates the eye tissues and converts to its active form to block inflammatory enzymes.

Berat Molekul

254,2800 g/mol

LogP

1,90

TPSA

86,20 Ų

Lipinski RO5

Lulus

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N

InChI

InChI=1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18)

Molecular Formula

C15H14N2O2

HBD / HBA

2 / 3

Ikatan yang Dapat Dirotasi

4

Atom Berat

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This non-steroidal anti-inflammatory eye drop is used to treat pain and inflammation after cataract surgery and to reduce the risk of swelling in the retina. It penetrates the eye tissues and converts to its active form to block inflammatory enzymes.

Yes, Nepafenac is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1021. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 151075. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.